{"id":"W3090227268","doi":"10.1111/bjd.19573","title":"Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":317,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"LEO Pharma","keywords":"Medicine; Placebo; Atopic dermatitis; Double blind; Dermatology; Randomized controlled trial; Internal medicine; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002776136,0.001547054,0.002511608,0.000322945,0.0003916679,0.001183826,0.0008074366,0.001533881,0.004976084],"category_scores_gemma":[0.001811978,0.0005225993,0.002417795,0.0003390174,0.0008567786,0.0008983111,0.0002952343,0.002778359,0.0007210664],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006424268,"about_ca_system_score_gemma":0.001112695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001013788,"about_ca_topic_score_gemma":0.002628921,"domain_scores_codex":[0.9992486,0.0004038345,0.00005551607,0.000114141,0.00006926781,0.0001087078],"domain_scores_gemma":[0.9991935,0.0002293541,0.0002133577,0.00006304082,0.00006396886,0.0002368441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.972937,0.003841354,0.0005041393,0.001086703,0.001452844,0.0000398657,0.0000491957,0.0002423373,0.003213104,0.00008466793,0.001195411,0.01535339],"study_design_scores_gemma":[0.9737726,0.0234767,0.001225227,0.0000420898,0.0006515449,0.00003214657,0.00001273101,0.0001473855,0.0001728459,0.0000613358,0.000396874,0.000008568465],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9663069,0.02165531,0.0009969394,0.001494283,0.00107037,0.003733141,0.001759708,0.0001827509,0.002800513],"genre_scores_gemma":[0.9780347,0.009741241,0.001644081,0.001799867,0.0007001469,0.003304803,0.001413488,0.00003959455,0.003321984],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004976084,"threshold_uncertainty_score":0.01664668,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03726144453849478,"score_gpt":0.3107739583228424,"score_spread":0.2735125137843477,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}